Dosage and administration
wet hands & wrists thoroughly with product and allow to dry without wiping
wet hands & wrists thoroughly with product and allow to dry without wiping
Drug Facts
Ethyl Alcohol 66.5%
Antiseptic
For handwashing to decrease bacteria on skin without soap and water.
For external use only. Flammable, keep away from fire or flame.
Do not use in eyes, if this happens, rinse thoroughly with water.
Stop use, ask doctor if irritation develops and persists for 72 hours. If ingested, get medical help or contact a Poison Control Center right away.
aloe vera, carbomer, D&C green # 5, D&C yellow # 10, fragrance, purified water, triethanolamine
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57685-7110-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5c0e-f424-e053-dadaa90a57ce | a530d5c7-e8bd-4c8e-9358-76c6799a6fb3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57685-7110-0 | Instant Hand Sanitizer | 0.00168 L in 1 POUCH | GEL | 0.00168 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57685-7110 | INSTANT HAND SANITIZER (ALCOHOL) GEL [APEX SANITATION, LLC] | 1 | Legacy NDC, 1 package rows | 20130403_a530d5c7-e8bd-4c8e-9358-76c6799a6fb3.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| alcohol | ACTIVE INGREDIENT | 3K9958V90M | 1 | |
| alcohol | ACTIVE MOIETY | 3K9958V90M | 1 | |
| aloe | INACTIVE INGREDIENT | V5VD430YW9 | 1 | |
| CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) | INACTIVE INGREDIENT | 59TL3WG5CO | 1 | |
| d&c green no. 5 | INACTIVE INGREDIENT | 8J6RDU8L9X | 1 | |
| d&c yellow no. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | 1 | |
| trolamine | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57685-7110 | 57685-7110-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| alcohol | 3K9958V90M | ACTIB |
| aloe | V5VD430YW9 | IACT |
| CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) | 59TL3WG5CO | IACT |
| d&c green no. 5 | 8J6RDU8L9X | IACT |
| d&c yellow no. 10 | 35SW5USQ3G | IACT |
| water | 059QF0KO0R | IACT |
| trolamine | 9O3K93S3TK | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / SUBLINGUAL | 0.23 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | GUM, CHEWING / ORAL | 2 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOAP / TOPICAL | 0.08 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL / TRANSDERMAL | 6 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 1 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL, METERED / TOPICAL | 20 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | GEL / DENTAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SUSPENSION, EXTENDED RELEASE / ORAL | 1 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CONCENTRATE / ORAL | 0.03 mg/1ml | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SOLUTION / ORAL | 8 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SHAMPOO / TOPICAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, CHEWABLE / ORAL | 4 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.02 %w/v | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | GUM, CHEWING / BUCCAL | 24 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | EMULSION / TOPICAL | 0.5 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOLUTION / NASAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | SOLUTION / ORAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / VAGINAL | 2 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / VAGINAL | 56 mg | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | TABLET, COATED / ORAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SOAP / TOPICAL | 1.4 %w/w | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SYRUP / ORAL | 4 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE / ORAL | 20 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | POWDER / ORAL | 48 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | ELIXIR / ORAL | 0.3 mg/15ml | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, METERED / RECTAL | ADJ PH | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | SHAMPOO / TOPICAL | 0.09 %w/w | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SOLUTION / RECTAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, LIQUID FILLED / ORAL | 1.51 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, COATED PELLETS / ORAL | 0.01 mg | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | SOAP / TOPICAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, COATED / ORAL | 2.5 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | POWDER, FOR SUSPENSION / ORAL | 76 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | LOTION / TOPICAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, FILM COATED / ORAL | 120 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SUSPENSION / ORAL | 20 mg/5ml | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SUPPOSITORY / RECTAL | 0.11 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | POWDER, FOR SOLUTION / ORAL | NA | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, DELAYED RELEASE / ORAL | 1 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | PASTE / DENTAL | NA | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | CAPSULE, EXTENDED RELEASE / ORAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| d&c green no. 5 | D&C GREEN NO. 5 | 8J6RDU8L9X | TABLET / ORAL | 0.03 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, DELAYED RELEASE / ORAL | 1.9 mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | GEL / TOPICAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL, METERED / TRANSDERMAL | 14 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | POWDER / TOPICAL | 0.02 mg/mg | ||
| d&c yellow no. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, EXTENDED RELEASE / ORAL | 3 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | DROPS / NASAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SPRAY / NASAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 02a4201d-2574-4dcd-9208-d56f45b58016 | a530d5c7-e8bd-4c8e-9358-76c6799a6fb3 | 2013-03-27 | Warnings | 02a4201d-2574-4dcd-9208-d56f45b58016 a530d5c7-e8bd-4c8e-9358-76c6799a6fb3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.